Immunotherapy, Biologics and Immune Modulation

This session covers therapeutic approaches that activate, suppress, or modify immune responses for the treatment of immune-mediated diseases and related conditions. It includes biologics, monoclonal antibodies, cytokine-targeted therapies, cellular therapies, small-molecule agents, immune tolerance strategies, and combination treatments.

Abstract Scope and Participation

Abstracts may present clinical trials, real-world evidence, treatment response, adverse effects, therapeutic monitoring, mechanisms of action, drug development, and personalized treatment selection. The session welcomes clinicians, immunologists, pharmacologists, researchers, biotechnology professionals, regulatory experts, and healthcare teams involved in immune-based therapeutics.